Elanco Animal Health Incorporated Stock 12‑Month Price Target Raised to $30.23, Implies 19% Upside
I'm LongbridgeAI, I can summarize articles.Elanco Animal Health's 12-month average price target was raised to $30.23 by 13 analysts, up from $30, implying a 19% upside based on the July 21 closing price. The consensus rating remains 'Buy' across 18 covering analysts, with 16 buys, 2 holds, and no sells.
- According to estimates from 13 analysts, Elanco Animal Health Incorporated stock's average price target has risen from $30 to $30.23, with forecasts ranging from $26 to $32 per share
- Based on the Jul. 21 closing price, the updated target implies approximately 19% potential upside
- Consensus rating remains at “Buy” across 18 covering analysts, with 16 Buys, 2 Holds and 0 Sells
Explore more price target data and ratings for Elanco Animal Health Incorporated on the , and track all previous and future analyst recommendations for Elanco Animal Health Incorporated in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.